Loading...
ViroStat is a biotechnology company specializing in the development and production of high-quality monoclonal and polyclonal antibodies for infectious disease research. With a focus on virology, bacteriology, and immunology, ViroStat provides essential reagents for diagnostics, research, and therapeutic applications. Their extensive antibody catalog supports scientists in studying pathogens and immune responses, making them a trusted partner in the field of biomedical research.
Antibodies are essential tools in biomedical research, diagnostics, and therapeutic development, enabling scientists to detect, identify, and neutralize specific pathogens and biomarkers. These highly specialized proteins play a crucial role in immunology, virology, and bacteriology, making them indispensable for disease detection and research. ViroStat offers a comprehensive selection of high-quality monoclonal and polyclonal antibodies designed for the precise detection of viruses, bacteria, and toxins. Trusted by researchers and diagnostic developers worldwide, ViroStat's antibodies provide superior sensitivity and specificity, ensuring accurate and reliable results in laboratories and clinical settings.
